Join us for a virtual conference as we introduce the 2021 ACR/VF Vasculitis Clinical Practice Treatment Guidelines to our community. These guidelines represent the first recommendations ever developed and endorsed by the American College of Rheumatology (ACR) and the Vasculitis Foundation (VF) for the management of:
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Giant cell arteritis (GCA)
- Granulomatosis with polyangiitis (GPA) and Microscopic polyangiitis (MPA)
- Polyarteritis nodosa (PAN)
- Takayasu arteritis (TAK)
These recommendations provide guidance regarding the evaluation and management of patients, including diagnostic strategies, use of pharmacologic agents, and surgical interventions. For session information and to register, visit:
https://www.vasculitisfoundation.org/acr-vf-2021-patient-treatment-conf/.
